Nordic AML posters at ASH 2023 – Webinar – 2024-03-12 – 15:00-16:20 (CET)
Join us for a webinar where we delve into the intricacies of showcased Nordic AML posters at the latest ASH Annual Meeting in December 2023. Here we aim for an opportunity to gain valuable insights, connect with peers, and stay at the forefront of AML innovation.
Join via Zoom: https://uu-se.zoom.us/j/63956689621
Tentative agenda (updated 2024-03-04)
15:00 – 15:05 – Welcome
15:05 – 15:15 – Elory Leonard, Stockholm, Sweden
Protective Function of Human Skin Mesenchymal Niches for Acute Myeloid Leukemia-Initiating Stem Cells
15:15 – 15:25 – Ida Vänttinen, Helsinki, Finland
Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia
15:25 – 15:35 – Claudia Schöllkopf, Copenhagen, Denmark
Dose Escalation of HLA-A2-WT1 CD3 T-Cell Bispecific Antibody in a Phase I Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
15:35 – 15:45 – Sofie Johansson Alm, Gothenburg, Sweden
Deep Sequencing Is a Widely Applicable Tool for Relapse Prediction in Acute Myeloid Leukemia with Mutated NPM1
15:45 – 15:55 – Øystein Sefland, Bergen, Norway
Intradermal Vaccination with Vididencel in MRD+ AML-Patients Leads to Increase in Antigen Presenting Cells and T-Cells to the Injection Site, Visualized Using Imaging Mass Cytometry, Showing Local Immune Cell Interactions Leading to Systemic Immune Responses
15:55 – 16:05 – Hanna Duàn, Helsinki, Finland
Primary Acute Myeloid Leukemia Cells Trigger Distinct Activation Patterns in Expanded NK Cells
16:05 – 16:15 – Somadri Ghosh, Lund, Sweden
H2-K1 on MLL-AF9 Leukemia Cells Facilitates the Escape of NK Cell-Mediated Immune Surveillance
16:15 – 16:25 – Jonas Bouhlal, Helsinki, Finland
High-Throughput Screens Identify NEDD8 Inhibition As a Strategy to Augment Natural Killer Cell Cytotoxicity Against Blood Cancers
16:25 – 16:30 – Closing remarks
Arranged by the NAMLG Educational Working Group (namlgewg@gmail.com)